1. Home
  2. GAME vs ATYR Comparison

GAME vs ATYR Comparison

Compare GAME & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameSquare Holdings Inc.

GAME

GameSquare Holdings Inc.

HOLD

Current Price

$0.36

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.51

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAME
ATYR
Founded
2011
2005
Country
United States
United States
Employees
N/A
58
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
51.7M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
GAME
ATYR
Price
$0.36
$0.51
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
604.5K
938.9K
Earning Date
04-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
65.14
N/A
EPS
N/A
N/A
Revenue
$44,999,302.00
N/A
Revenue This Year
$87.12
N/A
Revenue Next Year
$21.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.40
52 Week High
$1.09
$6.50

Technical Indicators

Market Signals
Indicator
GAME
ATYR
Relative Strength Index (RSI) 48.03 47.47
Support Level $0.26 $0.46
Resistance Level $0.47 $0.86
Average True Range (ATR) 0.03 0.03
MACD 0.00 0.00
Stochastic Oscillator 24.70 58.49

Price Performance

Historical Comparison
GAME
ATYR

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: